Laser treatment for new glaucoma patients without prior medication
Part of Eyes & vision clinical trials.
This study tests a new laser treatment called DSLT for people who have just been diagnosed with open-angle glaucoma or a similar condition like ocular hypertension. It aims to see if the laser can lower eye pressure by at least 20% after six months without needing any eye drops.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have been newly diagnosed with open-angle glaucoma, ocular hypertension, or a similar condition like pigment dispersion or pseudoexfoliation.
- You have never had any glaucoma treatment, including eye drops or laser.
- You have not had any previous glaucoma surgeries.
- You do not have other eye conditions like advanced cataracts, retinal disease, or a type of glaucoma caused by injury or other illness.
- You can keep your head and eyes still, and your pupil can shrink to 4 mm or less.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a laser treatment helps keep eye pressure stable in people with early glaucoma or high eye pressure who have not used any eye drops or medications before. It may be a good option if you are looking for a treatment that doesn't require daily eye drops.
This trial tests a laser treatment called DSLT to see how it affects eye pressure changes over 6 months. It may help people with open-angle glaucoma or high eye pressure who are currently using 0 to 3 types of pressure-lowering eye drops.
This trial is testing a laser treatment called DSLT to see if it can help people with glaucoma use fewer eye drops. It may be a good option if your eye pressure is already controlled with medication and you haven't had glaucoma surgery before.
This trial tests how well a laser treatment called selective laser trabeculoplasty works in people with open-angle glaucoma. It looks at results over 12 months to see if it helps lower eye pressure.
This trial compares two first treatments—laser therapy (SLT) or daily eye drops (latanoprost)—to lower eye pressure in people newly diagnosed with open-angle glaucoma or high eye pressure. It aims to find which approach works better as an initial therapy.
This trial tests a type of laser treatment (DSLT) for people of Asian descent who have normal tension glaucoma, where eye pressure stays below 21 mmHg. It aims to see if this laser can help control the disease and possibly reduce the need for eye drops.
Hear when a new Primary Open Angle Glaucoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.